Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

cord blood-derived expanded allogeneic natural killer cells

A preparation of human umbilical cord blood (UCB)-derived and ex vivo-expanded allogeneic natural killer (NK) cells, with immunomodulating and cytotoxic activities. Upon infusion of the cord blood-derived expanded allogeneic NK cells, these cells recognize and bind to tumor cells, and secrete perforins, granzymes, and cytokines, which cause cancer cell lysis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic CB-derived ex vivo-expanded NK cells
CB-derived expanded allogeneic NK cells
UCB-derived expanded allogeneic NK cells
umbilical cord blood-derived expanded allogeneic natural killer cells
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search